Non-invasive Flow Measurements in Patients With Lower Extremity Arterial Disease (LEAD)

Philips Clinical & Medical Affairs Global30 enrolled

Overview

This concerns a study with patients who will undergo endovascular treatment. Blood flow will be measured by 2D Duplex Ultrasound. Contrast data will be collected that will be processed offline.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Lower Extremity Arterial Disease

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients referred to the vascular surgery outpatient clinic (LUMC) with PAD * Age ≥18 years * Superficial femoral artery (SFA) stenosis (\>70% occluded) * Elective for a percutaneous transluminal angioplasty procedure * Written informed consent Exclusion Criteria: * Contraindications to angiography, such as severe renal insufficiency (eGFR\< 20) * Non-correctable bleeding disorder.

Locations (1)

Leiden University Medical Center

Leiden, Netherlands

RECRUITING

Outcomes

Primary Outcomes

blood flow

Repeatability and correlation of angiographic hemodynamic measurements compared with the golden standard 2D duplex ultrasound.

Time frame: performed during a regular PTA intervention

Central Contacts

Kirsten Huntjens

CONTACT

639839645 kirsten.huntjens@philips.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.